NO921697L - Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav - Google Patents

Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav

Info

Publication number
NO921697L
NO921697L NO92921697A NO921697A NO921697L NO 921697 L NO921697 L NO 921697L NO 92921697 A NO92921697 A NO 92921697A NO 921697 A NO921697 A NO 921697A NO 921697 L NO921697 L NO 921697L
Authority
NO
Norway
Prior art keywords
trfp
protein
peptide
isolated
house dust
Prior art date
Application number
NO92921697A
Other languages
English (en)
Other versions
NO921697D0 (no
Inventor
Malcolm L Gefter
Richard D Garman
Julia L Greenstein
Mei-Chang Kuo
Bruce L Rogers
Andrew W Brauer
Irwin J Griffith
Jay Morgenstern
Julian Bond
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Publication of NO921697D0 publication Critical patent/NO921697D0/no
Publication of NO921697L publication Critical patent/NO921697L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)

Abstract

I hovedsak rent, kovalent bundet humant T-celle- reaktivt felint protein (TRFPJ med omtrent 40.000 MW har blitt isolert fra støvsugerpose- ekstrakt erholdt ved affinitetsrensing av hus*-støv samlet opp fra flere hus med katter; DNA som koder for alt eller en del av TRFP eller peptidet; blandinger inneholdende et slikt protein eller peptid eller deler derav samt antistoff som er reaktive mot TRFP eller peptidet er beskrevet. Det er også beskrevet rekombinant TRFP eller peptic; -modifisert eller imitert TRFP peptider samt dere bruk for diagnostiske eller terapeutiske formål.
NO92921697A 1989-11-03 1992-04-30 Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav NO921697L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43156589A 1989-11-03 1989-11-03
PCT/US1990/006548 WO1991006571A1 (en) 1989-11-03 1990-11-02 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor

Publications (2)

Publication Number Publication Date
NO921697D0 NO921697D0 (no) 1992-04-30
NO921697L true NO921697L (no) 1992-07-03

Family

ID=23712496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921697A NO921697L (no) 1989-11-03 1992-04-30 Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav

Country Status (11)

Country Link
EP (1) EP0500785B1 (no)
JP (1) JP3251012B2 (no)
AT (1) ATE216401T1 (no)
AU (1) AU650249B2 (no)
CA (1) CA2073045C (no)
DE (1) DE69033949T2 (no)
DK (1) DK0500785T3 (no)
ES (1) ES2174822T3 (no)
FI (1) FI921979A0 (no)
NO (1) NO921697L (no)
WO (1) WO1991006571A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328991A (en) * 1989-11-03 1994-07-12 Immulogic Pharmaceutical Corp. Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US7288256B1 (en) 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
ATE382699T1 (de) * 1991-10-16 2008-01-15 Merck Patent Gmbh Verfahren zum entwurf von rekombitopen peptiden
WO1993008279A1 (en) * 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
IL105153A (en) * 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
US5968526A (en) * 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
ES2314515T3 (es) 1996-03-21 2009-03-16 Circassia Limited Peptidos cripticos y metodo para su identificacion.
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
CA2403292C (en) 2000-04-06 2011-02-08 Panacea Pharmaceuticals, Llc Microbial delivery system
US8246945B2 (en) 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
JP2004522432A (ja) 2000-12-22 2004-07-29 シノヴィス・リミテッド Ｔｏｌｌ関連レセプター（ｔｒｒ）シグナル伝達の調節方法
EP2292642A1 (en) 2003-06-10 2011-03-09 Opal Therapeutics Pty Ltd Immunomodulating compositions, uses therefor and processes for their production
EP2591786B1 (en) 2003-10-16 2017-04-12 Cancure Limited Immunomodulating compositions and uses therefor
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
EP2077821B1 (en) 2006-10-12 2019-08-14 The University Of Queensland Compositions and methods for modulating immune responses
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CN101820907B (zh) 2007-08-15 2013-05-01 切尔卡西亚有限公司 针对过敏原去敏化的肽
EP2231257A4 (en) 2007-12-24 2013-11-06 Univ Queensland APPLICATION METHOD
EP2247527A4 (en) 2008-02-07 2014-10-29 Univ Queensland PATCH PRODUCTION
WO2009140735A1 (en) 2008-05-23 2009-11-26 The University Of Queensland Analyte detection by microneedle patch with analyte selective reagents.
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
AU2009329806A1 (en) 2008-12-22 2010-07-01 The University Of Queensland Patch production
WO2012006677A1 (en) 2010-07-14 2012-01-19 The University Of Queensland Patch applying apparatus
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US11179553B2 (en) 2011-10-12 2021-11-23 Vaxxas Pty Limited Delivery device
CA2975275C (en) 2015-02-02 2023-08-29 Vaxxas Pty Limited Microprojection array applicator and method
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
EP3355981A4 (en) 2015-09-28 2019-05-22 Vaxxas Pty Limited MICROPROJECTION ARRANGEMENTS WITH IMPROVED SKIN-IMPROPER PROPERTIES AND METHOD THEREFOR
EP4306803A3 (en) 2017-03-31 2024-04-10 Vaxxas Pty Limited Device and method for coating surfaces
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
EP4218893A1 (en) 2017-08-04 2023-08-02 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (map)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy

Also Published As

Publication number Publication date
ES2174822T3 (es) 2002-11-16
CA2073045A1 (en) 1991-05-04
ATE216401T1 (de) 2002-05-15
WO1991006571A1 (en) 1991-05-16
FI921979A (fi) 1992-04-30
DE69033949T2 (de) 2002-11-14
AU650249B2 (en) 1994-06-16
DE69033949D1 (de) 2002-05-23
AU6733090A (en) 1991-05-31
NO921697D0 (no) 1992-04-30
CA2073045C (en) 2007-05-22
JPH05502445A (ja) 1993-04-28
FI921979A0 (fi) 1992-04-30
DK0500785T3 (da) 2002-08-19
EP0500785B1 (en) 2002-04-17
EP0500785A1 (en) 1992-09-02
JP3251012B2 (ja) 2002-01-28

Similar Documents

Publication Publication Date Title
NO921697D0 (no) Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav
DE60043402D1 (de) Diagnostisches und therapeutisches Epitop
AU3192889A (en) T cell activation markers
Mundy et al. Big and little forms of osteoclast activating factor
FI941757A (fi) Dermatofagoideista (talopölypunkki) peräisin olevien pääallergeenien T-soluepitoopit
HK1022918A1 (en) Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
SE9002589L (sv) Neutrofil-aktiverande peptid-2
ES2194838T3 (es) Enlazadores peptidicos ricos en serina.
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
AU626636B2 (en) Pancreatic islet cell antigens obtained by molecular cloning
Thomas et al. Fibronectin tetrapeptide is target for syphilis spirochete cytadherence.
WO1991008220A1 (en) A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
JO1671B1 (en) New ways to diagnose tuberculosis
DE3785664T2 (de) Pertussis-toxin-polypeptid und seine applikationen.
SE9002212D0 (sv) Igg binding protein
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
HK1014547A1 (en) Rabbit hemorrhagic disease virus (rhdv) recombinant capsids and proteins, diagnostic kits and vaccines containing them.
NO950526L (no) T-celleepitoper av raigresspollen-allergen
Onozaki et al. Production of an antibody against guinea pig MIF: II. Analysis of the antibody-reacting material using radiolabeled lymphokines
EP0662150A4 (en) MASPIN, NEW SERPIN WITH ANTI-TUMOR ACTIVITY.
Chersi et al. Preparation and utilization of fluorescent synthetic peptides
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B